Study of Anlotinib in Non-squamous NSCLC Patients Who Failed First-Line（ALTER-L020）
Clinical trial NCT03755869 · UNKNOWN
Trial details
- NCT number
- NCT03755869
- Sponsor
- First Affiliated Hospital Xi'an Jiaotong University
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-29
- Primary completion
- 2021-11-01
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.